Occurrence of the human tumor-specific antigen structure Gal1-3GalNAcα-(Thomsen-Friedenreich) and related structures on gut bacteria: Prevalence, immunochemical analysis and structural confirmation

Glycobiology

Volumn 21, Issue 10, 2011, Pages 1277-1289

  Henderson, Gemma ^a   Ulsemer, Philippe ^b   Schöber, Ute ^b,c   Löffler, Anja ^b   Alpert, Carl Alfred ^a   Zimmermann Kordmann, Martin ^c   Reutter, Werner ^c   Karsten, Uwe ^b   Goletz, Steffen ^b   Blaut, Michael ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GLYCOTOPE GMBH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bacteroides ovatus; cancer; CD176; gastrointestinal bacteria; Thomsen Friedenreich antigen

Indexed keywords

BACTERIAL POLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOSACCHARIDE; THOMSEN FRIEDENREICH ANTIGEN; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN STRUCTURE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTEROIDES OVATUS; CHEMICAL COMPOSITION; CONTROLLED STUDY; HUMAN; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; INTESTINE FLORA; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PREVALENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ANTIBODIES; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BACTEROIDETES; FECES; GASTROINTESTINAL TRACT; HUMANS;

BACTEROIDES OVATUS;

EID: 80052653430     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwr058     Document Type: Article

References (66)

1. Adluri S, Helling F, Ogata S, Zhang S, Itzkowitz SH, Lloyd KO, Livingston PO. 1995. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol Immunother. 41:185-192.
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol. 215:403-410.
3. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. 1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol. 56:1919-1925. (Pubitemid 20202165)
4. Apicella MA, Griffiss JM, Schneider H. 1994. Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A. Methods Enzymol. 235:242-252.
5. Baldus SE, Zirbes TK, Hanisch F-G, Kunze D, Shafizadeh ST, Nolden S, Mönig SP, Schneider PM, Karsten UR, Thiele J, et al. 2000. Thomsen-Friedenreich (TF) antigen presents as a prognostic factor in colorectal carcinoma. A clinicopathological study including 264 patients. Cancer. 88:536-543.
6. Barresi G, Vitarelli E, Giuffrè G, Grosso M, Tuccari G. 1999. Simple mucintype carbohydrate antigens in Helicobacter pylori-positive chronic active gastritis. Virchows Arch. 435:458-459.
7. Baumann H, Tzianabos AO, Brisson JR, Kasper DL, Jennings HJ. 1992. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry. 31:4081-4089.
8. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. 1995. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem. 230:229-238.
9. Boccardi V, Attina D, Girelli G. 1974. Influence of orally administered antibiotics on anti-T agglutinin of normal subjects and of cirrhotic patients. Vox Sang. 27:268-272.
10. Brockhausen I. 1999. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1473:67-95.
11. Brockhausen I. 2006. Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions. EMBO Rep. 7:599-604. (Pubitemid 43827326)
12. Butschak G, Karsten U. 2002. Isolation and characterization of Thomsen-Friedenreich-specific antibodies from human serum. Tumor Biol. 23:113-122. (Pubitemid 44858302)
13. Cao Y, Karsten UR, Liebrich W, Haensch W, Springer GF, Schlag PM. 1995. Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation. Cancer. 76:700-1708.
14. Cao Y, Merling A, Karsten U, Goletz S, Punzel M, Kraft R, Butschak G, Schwartz-Albiez R. 2008. Expression of CD175 (Tn), CD175s (sialosyl-Tn), and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells. Int J Cancer. 123:89-99. (Pubitemid 351705196)
15. Cao Y, Stosiek P, Springer GF, Karsten U. 1996. Thomsen- Friedenreichrelated carbohydrate antigens in normal adult human tissues: A systematic and comparative study. Histochem Cell Biol. 106:197-207. (Pubitemid 26281400)
16. Chen Y, Jain RK, Chandrasekan EV, Matta KL. 1995. Use of sialylated or sulfated derivatives and acrylamide copolymers of Galβ1,3GalNAcα-and GalNAcα-to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients. Glycoconj J. 12:55-62.
17. Clausen H, Stroud M, Parker J, Springer G, Sen-Itiroh H. 1988. Monoclonal antibodies directed to the blood group a associated structure, galactosyl-A: Specificity and relation to the Thomsen-Friedenreich antigen. Mol Immun. 25(2):199-204.
18. Cole JR, Chai B, Farris RJ, Wang Q, Kulam SA, McGarrell DM, Garrity GM, Tiedje JM. 2005. The Ribosomal Database Project (RDP-II): Sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res. 33:D294-D296. (Pubitemid 40207881)
19. Desai PR, Ujjainwala LH, Carlstedt SC, Springer GF. 1995. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. J Immunol Methods. 188:175-185. (Pubitemid 26020714)
20. Feizi T. 1985. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 314:53-57. (Pubitemid 15142022)
21. Fung PYS, Madaj M, Koganty RR, Longenecker BM. 1990. Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res. 50:4308-4314. (Pubitemid 20225670)
22. Goletz S, Cao Y, Danielczyk A, Ravn P, Schöber U, Karsten U. 2003. Thomsen-Friedenreich antigen: The "hidden" tumor antigen. Adv Exp Med Biol. 535:147-162.
23. Hakomori S. 1989. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 52:257-331.
24. Hanske L, Hussong R, Frank N, Gerhauser C, Blaut M, Braune A. 2005. Xanthohumol does not affect the composition of rat intestinal microbiota. Mol Nutr Food Res. 49:868-873. (Pubitemid 41411572)
25. Hara S, Yamaguchi M, Takemori Y, Furuhata K, Ogura H, Nakamura M. 1989. Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography. Anal Biochem. 179:162-166. (Pubitemid 19149640)
26. Hashimoto M, Kirikae F, Dohi T, Kusumoto S, Suda Y, Kirikae T. 2001. Structural elucidation of a capsular polysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease. Eur J Biochem. 268:3139-3144. (Pubitemid 32822986)
27. Hugenholtz P, Tyson GW, Blackall LL. 2001. Design and evaluation of 16S rRNA-targeted oligonucleotide probes for fluorescence in situ hybridization. In: Lieberman BA, editor. Methods in Molecular Biology. Totowa, USA: Humana Press.
28. Hull SR, Carraway KL. 1988. Mechanism of expression of Thomsen-Friedenreich (T) antigen at the cell surface of a mammary adenocarcinoma. FASEB J. 2:2380-2384.
29. Irazoqui FJ, Jansson B, Lopez PHH, Nores GA. 2001. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation. J Biochem. 130:33-37. (Pubitemid 32674562)
30. Jeschke U, Karsten U, Wiest I, Schulze S, Kuhn C, Friese K, Walzel H. 2006. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem Cell Biol. 126:437-444. (Pubitemid 44435899)
31. Kageyama A, Benno Y, Nakase T. 1999. Phylogenetic evidence for the transfer of Eubacterium lentum to the genus Eggerthella as Eggerthella lenta gen. nov., comb. nov. Int J Syst Bacteriol. 49(Pt 4):1725-1732. (Pubitemid 29519104)
32. Kamlage B, Hartmann L, Gruhl B, Blaut M. 2000. Linoleic acid conjugation by human intestinal microorganisms is inhibited by glucose and other substrates in vitro and in gnotobiotic rats. J Nutr. 130:2036-2039. (Pubitemid 30497541)
33. Karlyshev AV, Wren BW. 2001. Detection and initial characterization of novel capsular polysaccharide among diverse Campylobacter jejuni strains using alcian blue dye. J Clin Microbiol. 39:279-284. (Pubitemid 32059604)
34. Karsten U. 2002. CD176 Workshop panel report. In: Mason D, Simmons D, Buckley C, Schwartz-Albiez R, Hadam M, Saalmuller A, Clark E, Malavasi F, Morrissey JA, Vivier E, et al., editors. Leucocyte Typing VII. Oxford, UK: Oxford University Press.
35. Karsten U, Butschak G, Stahn R, Goletz S. 2010. A novel series of antihuman glycophorin A (CD235a) antibodies defining five extra- and intracellular epitopes. Int Immunopharm. 10: 1354-1360.
36. Kasper DL, Weintraub A, Lindberg AA, Lonngren J. 1983. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: Chemical and immunochemical characterization. J Bacteriol. 153:991-997. (Pubitemid 13165039)
37. Klaamas K, Kurtenkov O, Rittenhouse-Olson K, Brjalin V, Miljukhina L, Shljapnikova L, Engstrand L. 2002. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol Invest. 31:191-204. (Pubitemid 35397076)
38. Kodar K, Kurtenkov O, Klaamas K. 2009. The Thomsen-Friedenreich antigen and αGal-specific human IgG glycoforms: Concanavalin A reactivity and relation to survival of cancer Patients. Immunol Invest. 38:704-717.
39. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature. 414:555-558. (Pubitemid 33131539)
40. Kristiansen KA, Potthast A, Christensen BE. 2010. Periodate oxidation of polysaccharides for modification of chemical and physical properties. Carbohydr Res. 345:1264-1271.
41. Kurtenkov O, Klaamas K, Mensdorff-Pouilly S, Miljukhina L, Shljapnikova L, Chuzmarov V. 2007. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: Relation to survival. Acta Oncol. 46:316-323. (Pubitemid 46625032)
42. Kurtenkov O, Klaamas K, Miljukhina L. 1995. The lower level of natural anti-Thomsen-Friedenreich antigen (TFA) agglutinins in sera of patients with gastric cancer related to ABO(H) blood group phenotype. Int J Cancer. 60:781-785.
43. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
44. Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J. 1996. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem. 271:33325-33334. (Pubitemid 27010142)
45. MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T, et al. 1991. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunother. 11:292-305.
46. MacLean GD, Longenecker BM. 1991. Clinical significance of the Thomsen-Friedenreich antigen. Semin Cancer Biol. 2:433-439.
47. Nilsson C, Skoglund A, Moran AP, Annuk H, Engstrand L, Normark S. 2008. Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS One. 3:e3811.
48. Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL. 1991. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun. 59:2075-2082.
49. Sambrook J, Fritsch EF, Maniatis T. 1989. In: Ford N, Nolan C, editors. Molecular Cloning. A Laboratory Manual. Cold Spring Harbour, USA: Cold Spring Harbour Laboratory Press.
50. Schlepper-Schäfer J, Springer GF. 1989. Carcinoma autoantigens T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes. Biochim Biophys Acta. 1013:266-272. (Pubitemid 19240322)
51. Shigeoka H, Karsten U, Okuno K, Yasutomi M. 1999. Inhibition of liver metastases from neuraminidase-treated Colon 26 cells by an anti-Thomsen- Friedenreich-specific monoclonal antibody. Tumor Biol. 20:139-146. (Pubitemid 29200013)
52. Singhal A, Hakomori S. 1990. Molecular changes in carbohydrate antigens associated with cancer. Bioessays. 12:223-230. (Pubitemid 120000450)
53. Slovin SF, Ragupathi G, Musselli C, Fernandez C, Diani M, Verbel D, Danishefsky S, Livingston P, Scher HI. 2005. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer. Cancer Immunol Immunother. 54:694-702. (Pubitemid 40884166)
54. Smibert RM, Krieg NR. 1994. Phenotypic characterization. In: Gerhardt P, editor. Methods for General and Molecular Bacteriology. Washington, USA: American Society for Microbiology, Washington.
55. Springer GF. 1984. T and Tn, general carcinoma autoantigens. Science. 224:1198-1206. (Pubitemid 14109457)
56. Springer GF. 1997. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med. 75:594-602. (Pubitemid 27373602)
57. Springer GF, Desai PR, Murthy MS, Tegtmeyer H, Scanlon EF. 1979. Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them. Prog Allergy. 26:42-96. (Pubitemid 9133926)
58. Springer GF, Desai PR, Scanlon EF. 1976. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them. Cancer. 37:169-176.
59. Springer GF, Tegtmeyer H. 1981. Origin of anti-Thomsen-Friedenreich (T) and Tn agglutinins in man and in White Leghorn chicks. Br J Haematol. 47:453-460. (Pubitemid 12131643)
60. Takanami I. 1999. Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol Rep. 6:341-344.
61. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 76:4350-4354. (Pubitemid 9256559)
62. Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL. 1992. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem. 267:18230-18235.
63. Weintraub A, Zahringer U, Lindberg AA. 1985. Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343. Eur J Biochem. 151:657-661. (Pubitemid 16215803)
64. Woodward MP, Young WW, Bloodgood RA. 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods. 78:143-153. (Pubitemid 15076753)
65. Yu L-G. 2007. The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconj J. 24:411-420. (Pubitemid 47512574)
66. Zoetendal EG, Akkermans AD, De Vos WM. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 64:3854-3859. (Pubitemid 28462983)